{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:27:58Z","timestamp":1790800078410,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.lpm.2008.04.008","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T19:44:13Z","timestamp":1221162253000},"page":"1377-1390","source":"Crossref","is-referenced-by-count":7,"title":["Quelles donn\u00e9es \u00e9pid\u00e9miologiques sont n\u00e9cessaires pour la mise en place de la vaccination contre le papillomavirus humain?"],"prefix":"10.1016","volume":"37","author":[{"given":"Nubia","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Carole","family":"Jacquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2008.04.008_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2008.04.012","article-title":"Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2\/3 and invasive cervical cancer. The EDiTH III study","volume":"110","author":"Pr\u00e9tet","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.lpm.2008.04.008_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ije\/dyn033","article-title":"Smoking and Human Papillomavirus (HPV) infection:a pooled analysis of the International Agency for Research HPV Prevalence Surveys","volume":"37","author":"Vaccarella","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.lpm.2008.04.008_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ijc.23093","article-title":"Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2\/3) in France: EDiTH study","volume":"122","author":"Pr\u00e9tet","year":"2008","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.lpm.2008.04.008_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.23092","article-title":"Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study","volume":"122","author":"Pr\u00e9tet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2008.04.008_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.lpm.2008.04.008_bib6","first-page":"C1","article-title":"HPV and cervical cancer in the world: 2007 report: WHO\/ICO information centre on HPV and cervical cancer (HPV information centre)","volume":"25","author":"Castellsague","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2008.04.008_bib7","unstructured":"World Health Organization The current status of development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting, Geneva, 16-18 February 1999. pp 1\u201322."},{"key":"10.1016\/j.lpm.2008.04.008_bib8","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide: Globocan 2002. IARC Cancer base n(5, version 2.0 (Lyon, France: IARC, 2004). www.depdb.iarc.fr\/globocan\/GLOBOframe.htm, le 30 septembre 2004."},{"key":"10.1016\/j.lpm.2008.04.008_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24S3","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2008.04.008_bib10","first-page":"101","article-title":"High-Risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (Intercourse)","volume":"10","author":"Kjaer","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lpm.2008.04.008_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.lpm.2008.04.008_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2105\/AJPH.91.6.947","article-title":"Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women","volume":"91","author":"Marrazzo","year":"2001","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.OLQ.0000105327.40288.DB","article-title":"Human papillomavirus prevalence and types in newborns and parents: concordance and mode of transmission","volume":"31","author":"Smith","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"9490","key":"10.1016\/j.lpm.2008.04.008_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"IARC HPV. Prevalence Surveys Study Group Worlwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2008.04.008_bib15","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","article-title":"Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results","volume":"190","author":"Mu\u00f1oz","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib17","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.lpm.2008.04.008_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital papillomavirus infection in a cohort of closely followed adolescent women","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1471-0528.2002.01053.x","article-title":"High incidence of cervical human papillomavirus infection in women during their first sexual relationship","volume":"109","author":"Collins","year":"2002","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.lpm.2008.04.008_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","article-title":"Sexual behavior and partner characteristics are the predominant risk factors for genital papillomavirus infection in young women","volume":"174","author":"Burk","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behaviour, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lpm.2008.04.008_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/380466","article-title":"Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population","volume":"189","author":"Tarkowski","year":"2004","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.lpm.2008.04.008_bib25","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1158\/1055-9965.EPI-04-0754","article-title":"Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers","volume":"14","author":"Kjaer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.lpm.2008.04.008_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6600194","article-title":"Prevalence and determinants of human papillomavirus genital infection in men","volume":"86","author":"Franceschi","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lpm.2008.04.008_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.OLQ.0000085181.25063.6C","article-title":"Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study","volume":"30","author":"Matos","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib28","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/373901","article-title":"Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand","volume":"187","author":"Sukvirach","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.10825","article-title":"Prevalence of human papillomavirus infection in women in Busan, South Korea","volume":"103","author":"Shin","year":"2003","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.lpm.2008.04.008_bib30","first-page":"815","article-title":"A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cerncer","volume":"12","author":"Ferreccio","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lpm.2008.04.008_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.bjc.6601515","article-title":"Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study","volume":"90","author":"Thomas","year":"2004","journal-title":"Br J Cancer"},{"issue":"14","key":"10.1016\/j.lpm.2008.04.008_bib32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jnci\/83.14.997","article-title":"Determinants of genital papillomavirus infection in young women","volume":"83","author":"Ley","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2008.04.008_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.10936","article-title":"Human papillomavirus infection among women in South and North Vietnam","volume":"104","author":"Anh","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2008.04.008_bib34","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use and HPV infection: pooled analysis of the IARC HPV Prevalence Surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lpm.2008.04.008_bib35","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1054\/bjoc.2000.1523","article-title":"Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort","volume":"83","author":"Deacon","year":"2000","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.lpm.2008.04.008_bib36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/aje\/kwh115","article-title":"Cigarette smoking, oncogenic human papillomavirus, Ki antigen and cervical intraepithelial neoplasia","volume":"159","author":"Harris","year":"2004","journal-title":"Am J Epidemol"},{"key":"10.1016\/j.lpm.2008.04.008_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007435-199309000-00007","article-title":"Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon","volume":"20","author":"Bauer","year":"1993","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000292372","article-title":"Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study","volume":"39","author":"Poppe","year":"1995","journal-title":"Gynecol Obstet Invest"},{"issue":"21","key":"10.1016\/j.lpm.2008.04.008_bib39","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/jnci\/94.21.1604","article-title":"Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer","volume":"94","author":"Smith","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2008.04.008_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2008.04.008_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/infdis\/169.2.235","article-title":"Persistence of type-specific human papillomavirus infection among cytologically normal women","volume":"169","author":"Hildesheim","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.lpm.2008.04.008_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.lpm.2008.04.008_bib44","first-page":"485","article-title":"The natural history of type-specific human papillomavirus infections in female university students","volume":"12","author":"Richardson","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lpm.2008.04.008_bib45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/aje\/kwg171","article-title":"HPV Study Group Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study","volume":"158","author":"Molano","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/317638","article-title":"A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types","volume":"183","author":"Liaw","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"Schiffman","year":"2003","journal-title":"J Natl Inst Monogr"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"issue":"18","key":"10.1016\/j.lpm.2008.04.008_bib49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","article-title":"A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection","volume":"327","author":"Koutsky","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2008.04.008_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.lpm.2008.04.008_bib51","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.lpm.2008.04.008_bib52","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lpm.2008.04.008_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.lpm.2008.04.008_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","article-title":"Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking","volume":"31","author":"Castellsague","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2008.04.008_bib55","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirus infected- women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.lpm.2008.04.008_bib56","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23, 017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int J Cancer"},{"issue":"9599","key":"10.1016\/j.lpm.2008.04.008_bib57","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35, 509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2008.04.008_bib58","doi-asserted-by":"crossref","unstructured":"International Collaboration of Epidemiological studies of Cervical Cancer. Carcinoma of the cervix and reproductive factors: Collaborative reanalysis of individual data on 16,543 women with cervical cancer and 33,542 women without cervical cancer from 25 epidemiological studies. Int J Cancer. 2006; 119: 1108\u201324.","DOI":"10.1002\/ijc.21953"},{"key":"10.1016\/j.lpm.2008.04.008_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.21193","article-title":"The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence","volume":"117","author":"Garcia-Closas","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2008.04.008_bib60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.20257","article-title":"Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study","volume":"111","author":"Smith","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2008.04.008_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/oxfordjournals.jncimonographs.a003481","article-title":"Chapter 6: Immunosuppression and co-infection with HIV","volume":"31","author":"Palefsky","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.lpm.2008.04.008_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.jncimonographs.a003480","article-title":"Chapter 5: Viral and host factors in human papillomavirus Persistence and progression","author":"Wang","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"10.1016\/j.lpm.2008.04.008_bib63","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ijc.21956","article-title":"Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology","volume":"119","author":"Snijders","year":"2006","journal-title":"Int J Cancer"},{"issue":"9222","key":"10.1016\/j.lpm.2008.04.008_bib64","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(00)02402-8","article-title":"Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study","volume":"355","author":"Ylitalo","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.lpm.2008.04.008_bib65","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytological abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"issue":"suppl 3","key":"10.1016\/j.lpm.2008.04.008_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vaccine.2006.05.113","article-title":"Chapter 7: Achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2008.04.008_bib67","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjc.6602069","article-title":"Cervical cancer screening programmes and policies in 18 European countries","volume":"91","author":"Anttila","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lpm.2008.04.008_bib68","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0959-8049(00)00330-0","article-title":"Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness","volume":"36","author":"Van Ballegooijen","year":"2000","journal-title":"Eur J Cancer"},{"issue":"suppl 3","key":"10.1016\/j.lpm.2008.04.008_bib69","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2008.04.008_bib70","unstructured":"IARC Handbooks of Cancer Prevention. Vol 10 on Cervix Cancer Screening."},{"key":"10.1016\/j.lpm.2008.04.008_bib71","unstructured":"HPV Today (April 2005) Interview with Nick Day N\u00b0 06."},{"issue":"25","key":"10.1016\/j.lpm.2008.04.008_bib72","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2008.04.008_bib73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/514052","article-title":"Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: A study in Spain and Colombia","volume":"176","author":"Castellsague","year":"1997","journal-title":"J Infect Dis"},{"issue":"9576","key":"10.1016\/j.lpm.2008.04.008_bib74","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lpm.2008.04.008_bib75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"suppl 1","key":"10.1016\/j.lpm.2008.04.008_bib76","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1086\/425271","article-title":"Role of herd immunity in determining the effect of vaccines against sexually transmitted disease","volume":"191","author":"Garnett","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2008.04.008_bib77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Mu\u00f1oz","year":"2004","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.lpm.2008.04.008_bib78","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208004296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208004296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T23:24:40Z","timestamp":1557789880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498208004296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0755498208004296"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2008.04.008","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}